Luminal Breast Cancer Cryoablation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorLucía Graña López
About this trial
LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women
Eligibility criteria
Qualifiers
Postmenopausal women diagnosed with invasive breast cancer by core needle biopsy or vacuum-assisted biopsy
Unifocal
Lesion ≤ 2 cm (on ultrasound and contrast enhanced mammography)
No axillary lymphadenopathy on ultrasound
Disqualifiers
Infiltrating lobular carcinoma
Extensive in situ component
Multifocality or multicentricity
Contraindication for contrast mammography
Trial design
Treatments tested in this trial
- Cryoablation with liquid nitrogen (Prosense® system)
Treatment groups
140 Participants
are divided into 1 treatment groupSponsors and collaborators
Lucía Graña López
Lead sponsor
Hospital Universitario Lucus Augusti
Sponsor institution
Source ClinicalTrials.gov